Federal Register of Legislation - Australian Government

Skip to primary navigation Skip to primary content
Federal Register of Legislation Skip to Content
SearchOpen search

Primary content

Bookmark

this version | go to latest

Industry Research and Development (clinical trials, phase 0, I, II, III, pre-market pilot stage, pre-market pivotal stage, for an unapproved therapeutic good) Amendment (Minor Corrections) Determination 2022

Authoritative Version
  • - F2022N00150
  • No longer in force
This instrument makes amendments to determine that certain phases of clinical trials for an unapproved therapeutic good are core R&D activities for the purposes of exercising its power or performing its duty to make a finding pursuant to the Industry Research and Development Act 1986.
Administered by: Industry, Science, Energy and Resources
Registered 29 Jun 2022
Date of repeal 01 Jul 2022
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003
Help with file formats Help with file formats
Notifiable Instrument
 
F2022N00150 : Authoritative PDF Document : 0.7MB Primary Document Icon F2022N00150 : ZIP Document : 74KB
8 pages